The DOI matches its Crossref record; 325 of the 325 references it cites were found in a registry or an index.
TGF-β signaling in tumor suppression and cancer progression
Abstract
Epithelial and hematopoietic cells have a high turnover and their progenitor cells divide continuously, making them prime targets for genetic and epigenetic changes that lead to cell transformation and tumorigenesis. The consequent changes in cell behavior and responsiveness result not only from genetic alterations such as activation of oncogenes or inactivation of tumor suppressor genes, but also from altered production of, or responsiveness to, stimulatory or inhibitory growth and differentiation factors. Among these, transforming growth factor beta (TGF-beta) and its signaling effectors act as key determinants of carcinoma cell behavior. The autocrine and paracrine effects of TGF-beta on tumor cells and the tumor micro-environment exert both positive and negative influences on cancer development. Accordingly, the TGF-beta signaling pathway has been considered as both a tumor suppressor pathway and a promoter of tumor progression and invasion. Here we evaluate the role of TGF-beta in tumor development and attempt to reconcile the positive and negative effects of TGF-beta in carcinogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As previously mentioned in this review, TGF-β itself and its family members have been recognized to be involved in cancer development [81], and TGF-β possesses a pro-oncogenic role in MPM connected to immune suppression [82,83].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [81]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · cited 1×
“Together, all these changes result in a micro-environment that promotes tumor growth and invasion and angiogenesi”
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V, & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,866
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270 · cited 1×
“Resulting nucleotide additions or deletions give rise to a truncated TβRII, which is incapable of signalin”
BackgroundMunger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,995
NEW EMBO MEMBERS REVIEW: Transcriptional control by the TGF-beta/Smad signaling system
Massague, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.8.1745 · Cited by 1,966
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Massagué, J. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043051 · Cited by 1,899
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890 · cited 1×
“TGF-β inhibits the proliferation and functional differentiation of T lymphocytes, lymphokine-activated killer cells, NK cells, neutrophils, macrophages and B cell”
BackgroundDennler, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3091 · Cited by 1,793
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750 · cited 1×
“, are expected to enhance the migratory and invasive properties of endothelial cells required for angiogenesi”
BackgroundKehrl, J. H., Wakefield, L. M., Roberts, A. B., Jakowlew, S., Alvarez-Mon, M., Derynck, R., Sporn, M. B., & Fauci, A. S. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.5.1037 · Cited by 1,582
Self-citationThe urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<119::aid-ijc17>3.0.co;2-e · Cited by 1,552
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z · Cited by 1,546
Negative regulation of transforming growth factor-β by the proteoglycan decorin
Yamaguchi, Y., Mann, D. M., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346281a0 · Cited by 1,516
Identification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction
Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., & Matsumoto, K. (1995) · Science · doi:10.1126/science.270.5244.2008 · Cited by 1,343
Edwards, D. R., Murphy, G., Reynolds, J. J., Whitham, S. E., Docherty, A. J., Angel, P., & Heath, J. K. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02449.x · Cited by 1,221
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182
Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo
Crawford, S. E., Stellmach, V., Murphy-Ullrich, J. E., Ribeiro, S. M. F., Lawler, J., Hynes, R. O., Boivin, G. P., & Bouck, N. (1998) · Cell · doi:10.1016/s0092-8674(00)81460-9 · Cited by 1,174 · cited 1×
“For example, the extracellular matrix protein thrombospondi”
Cyclosporine induces cancer progression by a cell-autonomous mechanism
Hojo, M., Morimoto, T., Maluccio, M., Asano, T., Morimoto, K., Lagman, M., Shimbo, T., & Suthanthiran, M. (1999) · Nature · doi:10.1038/17401 · Cited by 1,149
Kaartinen, V., Voncken, J. W., Shuler, C., Warburton, D., Bu, D., Heisterkamp, N., & Groffen, J. (1995) · Nature Genetics · doi:10.1038/ng1295-415 · Cited by 1,031
Transcriptional Activators of TGF-β Responses: Smads
Derynck, R., Zhang, Y., & Feng, X.-H. (1998) · Cell · doi:10.1016/s0092-8674(00)81696-7 · Cited by 1,029
Self-citationA mechanism of repression of TGFbeta / Smad signaling by oncogenic Ras
Kretzschmar, M., Doody, J., Timokhina, I., & Massague, J. (1999) · Genes & Development · doi:10.1101/gad.13.7.804 · Cited by 1,004
Bhowmick, N. A., Ghiassi, M., Bakin, A., Aakre, M., Lundquist, C. A., Engel, M. E., Arteaga, C. L., & Moses, H. L. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.1.27 · Cited by 1,004
Yin, J. J., Selander, K., Chirgwin, J. M., Dallas, M., Grubbs, B. G., Wieser, R., Massagué, J., Mundy, G. R., & Guise, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3523 · Cited by 986
Knabbe, C., Lippman, M. E., Wakefield, L. M., Flanders, K. C., Kasid, A., Derynck, R., & Dickson, R. B. (1987) · Cell · doi:10.1016/0092-8674(87)90193-0 · Cited by 975
Self-citationKip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
Reynisdóttir, I., Polyak, K., Iavarone, A., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.15.1831 · Cited by 962
TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights
Moses, H. L., Yang, E. Y., & Pietenpol, J. A. (1990) · Cell · doi:10.1016/0092-8674(90)90155-8 · Cited by 959 · cited 1×
“TGF-β–mediated growth arrest and apoptosis Most pertinent to our understanding of the role of TGF-β in carcinoma development is the fact that TGF-β is a potent inducer of growth inhibition in several cell types, including epithelial cell”
BackgroundDatto, M. B., Li, Y., Panus, J. F., Howe, D. J., Xiong, Y., & Wang, X. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5545 · Cited by 950
Human Smad3 and Smad4 Are Sequence-Specific Transcription Activators
Zawel, L., Le Dai, J., Buckhaults, P., Zhou, S., Kinzler, K. W., Vogelstein, B., & Kern, S. E. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80061-1 · Cited by 939
Miettinen, P. J., Ebner, R., Lopez, A. R., & Derynck, R. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.6.2021 · Cited by 937
Self-citationTransforming growth factor–β3 is required for secondary palate fusion
Proetzel, G., Pawlowski, S. A., Wiles, M. V., Yin, M., Boivin, G. P., Howles, P. N., Ding, J., Ferguson, M. W. J., & Doetschman, T. (1995) · Nature Genetics · doi:10.1038/ng1295-409 · Cited by 908
Mutations in the SMAD4/DPC4 Gene in Juvenile Polyposis
Howe, J. R., Roth, S., Ringold, J. C., Summers, R. W., Järvinen, H. J., Sistonen, P., Tomlinson, I. P. M., Houlston, R. S., Bevan, S., Mitros, F. A., et al. (1998) · Science · doi:10.1126/science.280.5366.1086 · Cited by 907
Sato, Y., & Rifkin, D. B. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.1.309 · Cited by 905
Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. U., Williams, R. D., Bringman, T. S., & Berger, W. H. (1987) · PubMed · Cited by 898
Self-citationYang, X. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1280 · Cited by 889
Synergistic Signaling in Fetal Brain by STAT3-Smad1 Complex Bridged by p300
Nakashima, K., Yanagisawa, M., Arakawa, H., Kimura, N., Hisatsune, T., Kawabata, M., Miyazono, K., & Taga, T. (1999) · Science · doi:10.1126/science.284.5413.479 · Cited by 865
Defective Angiogenesis in Mice Lacking Endoglin
Li, D. Y., Sorensen, L. K., Brooke, B. S., Urness, L. D., Davis, E. C., Taylor, D. G., Boak, B. B., & Wendel, D. P. (1999) · Science · doi:10.1126/science.284.5419.1534 · Cited by 852 · cited 1×
“256 ) endoglin, an endothelially restricted TGF-β type III receptor (refs”
BackgroundOh, S. P., Seki, T., Goss, K. A., Imamura, T., Yi, Y., Donahoe, P. K., Li, L., Miyazono, K., ten Dijke, P., Kim, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.6.2626 · Cited by 851
Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L.-C., Bapat, B., Gallinger, S., Andrulis, I. L., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80128-2 · Cited by 845
Matrix metalloproteinases in tumor invasion and metastasis
Stamenkovic, I. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0379 · Cited by 815 · cited 1×
“12 ), which are frequently expressed by malignant cells, especially at sites of tumor cell invasio”
BackgroundInhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway
Ulloa, L., Doody, J., & Massagué, J. (1999) · Nature · doi:10.1038/17826 · Cited by 812
Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription
Zhang, Y., Feng, X.-H., & Derynck, R. (1998) · Nature · doi:10.1038/29814 · Cited by 809
Self-citationGrowth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation.
Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livingston, D. M., & Massague, J. (1990) · Cell · doi:10.1016/0092-8674(90)90251-9 · Cited by 797
Specificity, diversity, and regulation in TGF-beta superfamily signaling.
Piek, E., HELDIN, C., & ten Dijke, P. (1999) · PubMed · Cited by 783
Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.
Kehrl, J. H., Roberts, A. B., Wakefield, L. M., Jakowlew, S., Sporn, M. B., & Fauci, A. S. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.12.3855 · Cited by 759
The Transforming Growth Factor-βs
Roberts, A. B., & Sporn, M. B. (1990) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-49295-2_8 · Cited by 746
Risk for breast cancer development determined by mammographic parenchymal pattern
Wolfe, J. N. (1976) · Cancer · doi:10.1002/1097-0142(197605)37:5<2380::aid-cncr2820370530>3.0.co;2-# · Cited by 745
Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin.
Lyons, R. M., Gentry, L. E., Purchio, A. F., & Moses, H. L. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.4.1361 · Cited by 737
Crystal Structure of a Smad MH1 Domain Bound to DNA
Shi, Y., Wang, Y.-F., Jayaraman, L., Yang, H., Massagué, J., & Pavletich, N. P. (1998) · Cell · doi:10.1016/s0092-8674(00)81600-1 · Cited by 725
Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins
Hiraoka, N., Allen, E., Apel, I. J., Gyetko, M. R., & Weiss, S. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81768-7 · Cited by 712 · cited 1×
“, are expected to enhance the migratory and invasive properties of endothelial cells required for angiogenesi”
BackgroundPertovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., & Alitalo, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37365-9 · Cited by 694
Cdc25 cell-cycle phosphatase as a target of c-myc
Galaktionov, K., Chen, X., & Beach, D. (1996) · Nature · doi:10.1038/382511a0 · Cited by 690
Oft, M., Peli, J., Rudaz, C., Schwarz, H., Beug, H., & Reichmann, E. (1996) · Genes & Development · doi:10.1101/gad.10.19.2462 · Cited by 681
Hocevar, B. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1345 · Cited by 675
Smad3 Mutant Mice Develop Metastatic Colorectal Cancer
Zhu, Y., Richardson, J. A., Parada, L. F., & Graff, J. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81730-4 · Cited by 671 · cited 1×
“Mice with homozygous inactivation of the gene encoding Smad3 ( MADH3 ) have also been shown to develop colon carcinoma”
BackgroundOberhammer, F. A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A. F., Bursch, W., & Schulte-Hermann, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5408 · Cited by 668
Specificity, diversity, and regulation in TGF‐β superfamily signaling
PIEK, E., HELDIN, C., & DIJKE, P. T. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.15.2105 · Cited by 656
TGF-β Receptor Type II Deficiency Results in Defects of Yolk Sac Hematopoiesis and Vasculogenesis
Oshima, M., Oshima, H., & Taketo, M. M. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0259 · Cited by 645
Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., & Akhurst, R. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80127-0 · Cited by 628
Self-citationTGF-β signaling by Smad proteins
Miyazono, K. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00025-8 · Cited by 626
TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis
Oft, M., Heider, K.-H., & Beug, H. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00533-7 · Cited by 623
Takaesu, G., Kishida, S., Hiyama, A., Yamaguchi, K., Shibuya, H., Irie, K., Ninomiya-Tsuji, J., & Matsumoto, K. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80244-0 · Cited by 610
Intestinal Tumorigenesis in Compound Mutant Mice of both Dpc4(Smad4) and Apc Genes
Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Seldin, M. F., & Taketo, M. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81132-0 · Cited by 609
Van Obberghen-Schilling, E., Roche, N. S., Flanders, K. C., Sporn, M. B., & Roberts, A. B. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68561-8 · Cited by 601
Repression of p15INK4b expression by Myc through association with Miz-1
Staller, P., Peukert, K., Kiermaier, A., Seoane, J., Lukas, J., Karsunky, H., Möröy, T., Bartek, J., Massagué, J., Hänel, F., et al. (2001) · Nature Cell Biology · doi:10.1038/35070076 · Cited by 575
Madri, J. A., Pratt, B. M., & Tucker, A. M. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.4.1375 · Cited by 573
Abnormal angiogenesis but intact hematopoietic potential in TGF‐β type I receptor‐deficient mice
Larsson, J., Goumans, M., Sjöstrand, L. J., van Rooijen, M. A., Ward, D., Levéen, P., Xu, X., ten Dijke, P., Mummery, C. L., & Karlsson, S. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1663 · Cited by 563
A Smad Transcriptional Corepressor
Wotton, D., Lo, R. S., Lee, S., & Massagué, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80712-6 · Cited by 561
Interdependent SMAD and JNK Signaling in Transforming Growth Factor-β-mediated Transcription
Engel, M. E., McDonnell, M. A., Law, B. K., & Moses, H. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37413 · Cited by 531
Signaling of transforming growth factor‐β family members through Smad proteins
Itoh, S., Itoh, F., Goumans, M., & ten Dijke, P. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01828.x · Cited by 529
TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest
Ewen, M. E., Sluss, H. K., Whitehouse, L. L., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90723-4 · Cited by 528
Alliston, T., Choy, L., Ducy, P., Karsenty, G., & Derynck, R. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2254 · Cited by 526 · cited 1×
“, but they are also involved in TGF-β–mediated repression of transcriptio”
BackgroundSelf-citationFeng, X.-H., Zhang, Y., Wu, R.-Y., & Derynck, R. (1998) · Genes & Development · doi:10.1101/gad.12.14.2153 · Cited by 525
Self-citationDennis, P. A., & Rifkin, D. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.2.580 · Cited by 516
Latent transforming growth factor-β: Structural features and mechanisms of activation
Munger, J. S., Harpel, J. G., Gleizes, P.-E., Mazzieri, R., Nunes, I., & Rifkin, D. B. (1997) · Kidney International · doi:10.1038/ki.1997.188 · Cited by 511
TGF-β-stimulated cooperation of Smad proteins with the coactivators CBP/p300
Janknecht, R., Wells, N. J., & Hunter, T. (1998) · Genes & Development · doi:10.1101/gad.12.14.2114 · Cited by 507
Verschueren, K., Remacle, J. E., Collart, C., Kraft, H., Baker, B. S., Tylzanowski, P., Nelles, L., Wuytens, G., Su, M.-T., Bodmer, R., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20489 · Cited by 506
Negative Feedback Regulation of TGF-β Signaling by the SnoN Oncoprotein
Stroschein, S. L., Wang, W., Zhou, S., Zhou, Q., & Luo, K. (1999) · Science · doi:10.1126/science.286.5440.771 · Cited by 492
TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b
Seoane, J., Pouponnot, C., Staller, P., Schader, M., Eilers, M., & Massagué, J. (2001) · Nature Cell Biology · doi:10.1038/35070086 · Cited by 489
Datto, M. B., Frederick, J. P., Pan, L., Borton, A. J., Zhuang, Y., & Wang, X.-F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2495 · Cited by 473 · cited 1×
“, although this phenotype was not seen in two similar studie”
BackgroundThe Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling
Luo, K., Stroschein, S. L., Wang, W., Chen, D., Martens, E., Zhou, S., & Zhou, Q. (1999) · Genes & Development · doi:10.1101/gad.13.17.2196 · Cited by 468
Schultz-Cherry, S. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.4.923 · Cited by 468 · cited 1×
“For example, the extracellular matrix protein thrombospondi”
Interaction between Wnt and TGF-β signalling pathways during formation of Spemann's organizer
Nishita, M., Hashimoto, M. K., Ogata, S., Laurent, M. N., Ueno, N., Shibuya, H., & Cho, K. W. Y. (2000) · Nature · doi:10.1038/35001602 · Cited by 465
Yang, E. Y., & Moses, H. L. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.731 · Cited by 464
A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.
Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., & Böttinger, E. P. (2000) · PubMed · Cited by 461
Interaction and Functional Cooperation of PEBP2/CBF with Smads
Hanai, J.-I., Chen, L. F., Kanno, T., Ohtani-Fujita, N., Kim, W. Y., Guo, W.-H., Imamura, T., Ishidou, Y., Fukuchi, M., Shi, M.-J., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31577 · Cited by 449
Yanagisawa, J., Yanagi, Y., Masuhiro, Y., Suzawa, M., Watanabe, M., Kashiwagi, K., Toriyabe, T., Kawabata, M., Miyazono, K., & Kato, S. (1999) · Science · doi:10.1126/science.283.5406.1317 · Cited by 445 · cited 1×
“48 ); nuclear receptors such as the vitamin D3 (ref”
BackgroundMyeroff, L. L., Parsons, R. E., Kim, S., Hedrick, L., Cho, K. R., Orth, K., Mathis, J. M., Kinzler, K. W., Lutterbaugh, J., & Park, K. (1995) · PubMed · Cited by 445
Hanafusa, H., Ninomiya-Tsuji, J., Masuyama, N., Nishita, M., Fujisawa, J.-I., Shibuya, H., Matsumoto, K., & Nishida, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27161 · Cited by 442
Labbé, E., Letamendia, A., & Attisano, L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150152697 · Cited by 440 · cited 1×
“For example, signaling by Wnt differentiation factors, which direct tissue specification and growth control, can intersect with TGF-β/Smad signaling because Smad3 can interact directly with β-catenin and LEF/TCF—transcription regulators of Wnt signalin”
BackgroundArthur, H. M., Ure, J., Smith, A. J. H., Renforth, G., Wilson, D. I., Torsney, E., Charlton, R., Parums, D. V., Jowett, T., Marchuk, D. A., et al. (2000) · Developmental Biology · doi:10.1006/dbio.1999.9534 · Cited by 436
Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects
Chang, H., Huylebroeck, D., Verschueren, K., Guo, Q., Matzuk, M. M., & Zwijsen, A. (1999) · Development · doi:10.1242/dev.126.8.1631 · Cited by 435
TGF-β signaling by Smad proteins
Miyazono, K., Ten Dijke, P., & Heldin, C.-H. (2000) · Advances in Immunology · doi:10.1016/s0065-2776(00)75003-6 · Cited by 433
Piek, E., Moustakas, A., Kurisaki, A., Heldin, C.-H., & Dijke, P. T. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.24.4557 · Cited by 426
A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA
Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., & Böttinger, E. P. (2000) · Genes & Development · doi:10.1101/gad.14.2.187 · Cited by 421
Park, K., Kim, S. J., Bang, Y. J., Park, J. G., Kim, N. K., Roberts, A. B., & Sporn, M. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8772 · Cited by 418
Derynck, R., & Feng, X.-H. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00017-6 · Cited by 415
Self-citationProteases in invasion: matrix metalloproteinases
Stetler-Stevenson, W. G., & Yu, A. E. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0365 · Cited by 411 · cited 1×
“12 ), which are frequently expressed by malignant cells, especially at sites of tumor cell invasio”
BackgroundTorre-Amione, G., Beauchamp, R. D., Koeppen, H., Park, B. H., Schreiber, H., Moses, H. L., & Rowley, D. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1486 · Cited by 403
Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF-β
Feng, X.-H., Lin, X., & Derynck, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.19.5178 · Cited by 397
Self-citationPardali, K., Kurisaki, A., Morén, A., ten Dijke, P., Kardassis, D., & Moustakas, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909467199 · Cited by 392
Grady, W. M., Myeroff, L. L., Swinler, S. E., Rajput, A., Thiagalingam, S., Lutterbaugh, J., Neumann, A., Brattain, M. G., Chang, J., Kim, S., et al. (1999) · PubMed · Cited by 391
The Immunophilin FKBP12 Functions as a Common Inhibitor of the TGFβ Family Type I Receptors
Wang, T., Li, B.-Y., Danielson, P. D., Shah, P. C., Rockwell, S., Lechleider, R. J., Martin, J., Manganaro, T., & Donahoe, P. K. (1996) · Cell · doi:10.1016/s0092-8674(00)80116-6 · Cited by 388
Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5
Yang, X., Castilla, L. H., Xu, X., Li, C., Gotay, J., Weinstein, M., Liu, P. P., & Deng, C.-X. (1999) · Development · doi:10.1242/dev.126.8.1571 · Cited by 388
Inactivation of the Type II Receptor Reveals Two Receptor Pathways for the Diverse TGF-β Activities
Chen, R.-H., Ebner, R., & Derynck, R. (1993) · Science · doi:10.1126/science.8388126 · Cited by 384
Self-citationRequirement of Type III TGF-β Receptor for Endocardial Cell Transformation in the Heart
Brown, C. B., Boyer, A. S., Runyan, R. B., & Barnett, J. V. (1999) · Science · doi:10.1126/science.283.5410.2080 · Cited by 383
Regulation of the Proinflammatory Effects of Fas Ligand (CD95L)
Chen, J.-J., Sun, Y., & Nabel, G. J. (1998) · Science · doi:10.1126/science.282.5394.1714 · Cited by 383 · cited 1×
“Indeed, Fas ligand–expressing carcinoma cells underwent neutrophil-mediated rejection, but this rejection did not occur at a site with high levels of TGF-β or when TGF-β1 was injected at the tumor sit”
Backgroundlavarone, A., & Massagué, J. (1997) · Nature · doi:10.1038/387417a0 · Cited by 377
Akiyoshi, S., Inoue, H., Hanai, J.-I., Kusanagi, K., Nemoto, N., Miyazono, K., & Kawabata, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.35269 · Cited by 373
The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3
Kurokawa, M., Mitani, K., Irie, K., Matsuyama, T., Takahashi, T., Chiba, S., Yazaki, Y., Matsumoto, K., & Hirai, H. (1998) · Nature · doi:10.1038/27945 · Cited by 371
Molecular effects of paclitaxel: Myths and reality (a critical review)
Blagosklonny, M. V., & Fojo, T. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991008)83:2<255::aid-ijc18>3.0.co;2-x · Cited by 366
Mechanism of TGFβ receptor inhibition by FKBP12
Chen, Y.-G., Liu, F., & Massagué, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3866 · Cited by 363
Signaling inputs converge on nuclear effectors in TGF-β signaling
ten Dijke, P., Miyazono, K., & Heldin, C.-H. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01519-4 · Cited by 362 · cited 1×
“The transcriptional activation by Smads, through their physical interactions and functional cooperativity with transcription factors, allows crosstalk with other signaling pathway”
BackgroundArteaga, C. L., Hurd, S. D., Winnier, A. R., Johnson, M. D., Fendly, B. M., & Forbes, J. T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116871 · Cited by 359
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
De Souza, A. T., Hankins, G. R., Washington, M. K., Orton, T. C., & Jirtle, R. L. (1995) · Nature Genetics · doi:10.1038/ng1295-447 · Cited by 355
Induction of Inhibitory Smad6 and Smad7 mRNA by TGF-β Family Members
Afrakhte, M., Morén, A., Jossan, S., Itoh, S., Sampath, K., Westermark, B., Heldin, C.-H., Heldin, N.-E., & ten Dijke, P. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9170 · Cited by 353
TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation
Perlman, R., Schiemann, W. P., Brooks, M. W., Lodish, H. F., & Weinberg, R. A. (2001) · Nature Cell Biology · doi:10.1038/35087019 · Cited by 349
Hahm, K.-B., Cho, K., Lee, C., Im, Y.-H., Chang, J., Choi, S.-G., Sorensen, P. H. B., Thiele, C. J., & Kim, S.-J. (1999) · Nature Genetics · doi:10.1038/13854 · Cited by 348 · cited 1×
“The EWS-FLI1 oncogene, which incorporates a partial coding sequence for the Ets family transcription factor Fli-1 and was first identified in Ewing sarcoma, represses expression of TβRII and may account for decreased TGF-β responsivenes”
BackgroundRole of Ras and Mapks in TGFβ signaling
Mulder, K. M. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00026-x · Cited by 348
Gum, R., Lengyel, E., Juarez, J., Chen, J. H., Sato, H., Seiki, M., & Boyd, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10672 · Cited by 345
ATF-2 Is a Common Nuclear Target of Smad and TAK1 Pathways in Transforming Growth Factor-β Signaling
Sano, Y., Harada, J., Tashiro, S., Gotoh-Mandeville, R., Maekawa, T., & Ishii, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8949 · Cited by 345
Butta, A., MacLennan, K., Flanders, K. C., Sacks, N. P. M., Smith, I., McKinna, A., Dowsett, M., Wakefield, L. M., Sporn, M. B., & Baum, M. (1992) · PubMed · Cited by 343
Wang, J., Sun, L., Myeroff, L., Wang, X., Gentry, L. E., Yang, J., Liang, J., Zborowska, E., Markowitz, S., Willson, J. K. V., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.22044 · Cited by 337
TAK1 Mediates the Ceramide Signaling to Stress-activated Protein Kinase/c-Jun N-terminal Kinase
Shirakabe, K., Yamaguchi, K., Shibuya, H., Irie, K., Matsuda, S., Moriguchi, T., Gotoh, Y., Matsumoto, K., & Nishida, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8141 · Cited by 335
Fakhrai, H., Dorigo, O., Shawler, D. L., Lin, H., Mercola, D., Black, K. L., Royston, I., & Sobol, R. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2909 · Cited by 334
Macrophage-derived angiogenesis factors
Sunderkötter, C., Goebeler, M., Schulze-Osthoff, K., Bhardwaj, R., & Sorg, C. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90077-y · Cited by 332 · cited 1×
“Indirect stimulation of angiogenesis by TGF-β1 may occur through the potent chemoattractant activity of TGF-β for monocytes, which release angiogenic cytokine”
BackgroundSmads bind directly to the Jun family of AP-1 transcription factors
Liberati, N. T., Datto, M. B., Frederick, J. P., Shen, X., Wong, C., Rougier-Chapman, E. M., & Wang, X.-F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4844 · Cited by 327 · cited 1×
“For example, Smad3 can interact with bZIP transcription factors such as c-Jun (refs”
BackgroundCoffey, R. J., Bascom, C. C., Sipes, N. J., Graves-Deal, R., Weissman, B. E., & Moses, H. L. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.8.3088 · Cited by 322
Chen, C.-R., Kang, Y., & Massagué, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.992 · Cited by 320
Sun, L., Wu, G., Willson, J. K., Zborowska, E., Yang, J., Rajkarunanayake, I., Wang, J., Gentry, L. E., Wang, X. F., & Brattain, M. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47215-8 · Cited by 319
Transforming growth factor-β: pleiotropic role in the regulation of hematopoiesis
Fortunel, N. O., Hatzfeld, A., & Hatzfeld, J. A. (2000) · Blood · doi:10.1182/blood.v96.6.2022 · Cited by 315
Chung, K.-Y., Agarwal, A., Uitto, J., & Mauviel, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.3272 · Cited by 315
Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency
Tang, B., Böttinger, E. P., Jakowlew, S. B., Bagnall, K. M., Mariano, J., Anver, M. R., Letterio, J. J., & Wakefield, L. M. (1998) · Nature Medicine · doi:10.1038/nm0798-802 · Cited by 314
Transforming Growth Factor β Activation of p44mapk in Proliferating Cultures of Epithelial Cells
Hartsough, M. T., & Mulder, K. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7117 · Cited by 310
The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function
Zhang, Y., Musci, T., & Derynck, R. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00123-0 · Cited by 309
Self-citationWikström, P., Stattin, P., Franck-Lissbrant, I., Damber, J.-E., & Bergh, A. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980915)37:1<19::aid-pros4>3.0.co;2-3 · Cited by 307
Jeffers, M., Rong, S., & Vande Woude, G. F. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1115 · Cited by 307
Kaji, H., Canaff, L., Lebrun, J.-J., Goltzman, D., & Hendy, G. N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061358098 · Cited by 300 · cited 1×
“Perhaps conceptually similar, menin, a putative tumor suppressor associated with multiple endocrine neoplasia type 1 (MEN1), interacts with Smad3 in the nucleus, and its inactivation suppresses Smad3-mediated transcription and TGF-β-induced response”
BackgroundCzarniecki, C. W., Chiu, H. H., Wong, G. H. W., McCabe, S. M., & Palladino, M. A. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.12.4217 · Cited by 294
Potts, J. D., & Runyan, R. B. (1989) · Developmental Biology · doi:10.1016/0012-1606(89)90111-5 · Cited by 292
Goggins, M., Shekher, M. C., Turnacioglu, K. K., Yeo, C. J., Hruban, R. H., & Kern, S. E. (1998) · PubMed · Cited by 288
Lehmann, K., Janda, E., Pierreux, C. E., Rytömaa, M., Schulze, A., McMahon, M., Hill, C. S., Beug, H., & Downward, J. (2000) · Genes & Development · doi:10.1101/gad.181700 · Cited by 287
Hua, X., Liu, X., Ansari, D. O., & Lodish, H. F. (1998) · Genes & Development · doi:10.1101/gad.12.19.3084 · Cited by 283
Battifora, H. (1976) · Cancer · doi:10.1002/1097-0142(197605)37:5<2275::aid-cncr2820370518>3.0.co;2-3 · Cited by 281
Rotello, R. J., Lieberman, R. C., Purchio, A. F., & Gerschenson, L. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3412 · Cited by 275
Tumor Suppressor Smad4 Is a Transforming Growth Factor β-Inducible DNA Binding Protein
Yingling, J. M., Datto, M. B., Wong, C., Frederick, J. P., Liberati, N. T., & Wang, X.-F. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7019 · Cited by 272
Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis
Schwarte-Waldhoff, I., Volpert, O. V., Bouck, N. P., Sipos, B., Hahn, S. A., Klein-Scory, S., Lüttges, J., Klöppel, G., Graeven, U., Eilert-Micus, C., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9624 · Cited by 266
Wong, C., Rougier-Chapman, E. M., Frederick, J. P., Datto, M. B., Liberati, N. T., Li, J.-M., & Wang, X.-F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1821 · Cited by 261
A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif
Larisch, S., Yi, Y., Lotan, R., Kerner, H., Eimerl, S., Tony Parks, W., Gottfried, Y., Birkey Reffey, S., de Caestecker, M. P., Danielpour, D., et al. (2000) · Nature Cell Biology · doi:10.1038/35046566 · Cited by 259
The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer
Kleeff, J., Ishiwata, T., Maruyama, H., Friess, H., Truong, P., Büchler, M. W., Falb, D., & Korc, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202909 · Cited by 258
de Jong, J. S., van Diest, P. J., van der Valk, P., & Baak, J. P. A. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199801)184:1<53::aid-path6>3.0.co;2-7 · Cited by 257
de Jong, J. S., van Diest, P. J., van der Valk, P., & Baak, J. P. A. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199801)184:1<96::aid-path989>3.0.co;2-m · Cited by 256
Claassen, G. F., & Hann, S. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150006697 · Cited by 256
Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer.
Bubb, V., Curtis, L. J., Cunningham, C., Dunlop, M. G., Carothers, A. D., Rg, M., White, S., Bird, C. C., & Wyllie, A. H. (1996) · PubMed · Cited by 246
Lüttges, J., Galehdari, H., Bröcker, V., Schwarte-Waldhoff, I., Henne-Bruns, D., Klöppel, G., Schmiegel, W., & Hahn, S. A. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64123-5 · Cited by 241
Regulation of Smad signalling by protein associations and signalling crosstalk
Zhang, Y., & Derynck, R. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01579-2 · Cited by 241 · cited 1×
“The transcriptional activation by Smads, through their physical interactions and functional cooperativity with transcription factors, allows crosstalk with other signaling pathway”
BackgroundSelf-citationHaploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice
Xu, X., Brodie, S. G., Yang, X., Im, Y.-H., Parks, W. T., Chen, L., Zhou, Y.-X., Weinstein, M., Kim, S.-J., & Deng, C.-X. (2000) · Oncogene · doi:10.1038/sj.onc.1203504 · Cited by 239
Letterio, J. J., Geiser, A. G., Kulkarni, A. B., Dang, H., Kong, L., Nakabayashi, T., Mackall, C. L., Gress, R. E., & Roberts, A. B. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119017 · Cited by 232
Warner, B. J., Blain, S. W., Seoane, J., & Massagué, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5913 · Cited by 230
Role of TAK1 and TAB1 in BMP signaling in early Xenopus development
Shibuya, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.4.1019 · Cited by 229
Chen, R.-H., Chang, M.-C., Su, Y.-H., Tsai, Y.-T., & Kuo, M.-L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23013 · Cited by 227
Activation of p21ras by transforming growth factor beta in epithelial cells.
Mulder, K. M., & Morris, S. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42722-6 · Cited by 223
TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G1 arrest
Petritsch, C., Beug, H., Balmain, A., & Oft, M. (2000) · Genes & Development · doi:10.1101/gad.854200 · Cited by 223 · cited 1×
“The regulatory roles of these proteins are well documented, but there is no convincing evidence to show that these WD-repeat proteins act as effectors of TGF-β responses, with the exception of the Bα subunit of protein phosphatase 2A, which may be involved in growth arrest through inactivation of the S6 kinase pathwa”
BackgroundSelf-citationEngle, S. J., Hoying, J. B., Boivin, G. P., Ormsby, I., Gartside, P. S., & Doetschman, T. C. (1999) · PubMed · Cited by 216
Bidirectional regulation of macrophage function by TGF-β
Ashcroft, G. S. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00257-9 · Cited by 216 · cited 1×
“Indirect stimulation of angiogenesis by TGF-β1 may occur through the potent chemoattractant activity of TGF-β for monocytes, which release angiogenic cytokine”
BackgroundShen, X., Hu, P. P.-C., Liberati, N. T., Datto, M. B., Frederick, J. P., & Wang, X.-F. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.12.3309 · Cited by 215 · cited 1×
“The receptor-activated Smads are linked to the general transcriptional machinery through a direct physical interaction with the transcriptional coactivator CBP/p300, which is essential for the transcriptional activation function of Smad”
BackgroundTransforming Growth Factor-β: Latent Forms, Binding Proteins and Receptors
Miyazono, K., Ichijo, H., & Heldin, C.-H. (1993) · Growth Factors · doi:10.3109/08977199309029130 · Cited by 209
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60740-x · Cited by 208
Yamada, T., De Souza, A. T., Finkelstein, S., & Jirtle, R. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10351 · Cited by 208
Wieser, R., Attisano, L., Wrana, J. L., & Massagué, J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7239-7247.1993 · Cited by 206
Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice.
Takaku, K., Miyoshi, H., Matsunaga, A., Oshima, M., Sasaki, N., & Taketo, M. M. (1999) · PubMed · Cited by 198
Epithelial Cell Plasticity in Development and Tumor Progression
Thiery, J. P., & Chopin, D. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006256219004 · Cited by 197
Xu, J., & Attisano, L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4820 · Cited by 197
Böttinger, E. P., Jakubczak, J. L., Haines, D. C., Bagnall, K. M., & Wakefield, L. M. (1997) · PubMed · Cited by 196
A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor
Chen, R.-H., Miettinen, P. J., Maruoka, E. M., Choy, L., & Derynck, R. (1995) · Nature · doi:10.1038/377548a0 · Cited by 196
Self-citationDickson, R. B., Kasid, A., Huff, K. K., Bates, S. E., Knabbe, C., Bronzert, D., Gelmann, E. P., & Lippman, M. E. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.3.837 · Cited by 194
Sandhu, C., Garbe, J., Bhattacharya, N., Daksis, J., Pan, C.-H., Yaswen, P., Koh, J., Slingerland, J. M., & Stampfer, M. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2458 · Cited by 194
The latent transforming growth factor β binding protein (LTBP) family
Öklü, R., & Hesketh, R. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3520601 · Cited by 193
SMAD3 represses androgen receptor-mediated transcription.
Hayes, S. A., Zarnegar, M. A., Sharma, M., Yang, F., Peehl, D. M., ten Dijke, P., & Sun, Z. (2001) · PubMed · Cited by 192
Shih, W.-L., Kuo, M.-L., Chuang, S.-E., Cheng, A.-L., & Doong, S.-L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003578200 · Cited by 189
Critical Role of Smads and AP-1 Complex in Transforming Growth Factor-β-dependent Apoptosis
Yamamura, Y., Hua, X., Bergelson, S., & Lodish, H. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006023200 · Cited by 188
Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis
Kim, S.-J., Im, Y.-H., Markowitz, S. D., & Bang, Y.-J. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00039-8 · Cited by 188
Chen, R.-H., Su, Y.-H., Chuang, R. L., & Chang, T.-Y. (1998) · Oncogene · doi:10.1038/sj.onc.1202111 · Cited by 186
Portella, G., Cumming, S. A., Liddell, J., Cui, W., Ireland, H., Akhurst, R. J., & Balmain, A. (1998) · PubMed · Cited by 185
Self-citationSelvakumaran, M., Lin, H. K., Sjin, R. T., Reed, J. C., Liebermann, D. A., & Hoffman, B. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2352 · Cited by 183
Lakkis, M. M., & Epstein, J. A. (1998) · Development · doi:10.1242/dev.125.22.4359 · Cited by 183
Geiser, A. G., Letterio, J. J., Kulkarni, A. B., Karlsson, S., Roberts, A. B., & Sporn, M. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.9944 · Cited by 179
Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer
Ivanovic, V., Melman, A., Davis-Joseph, B., Valcic, M., & Geliebter, J. (1995) · Nature Medicine · doi:10.1038/nm0495-282 · Cited by 176
STRAP and Smad7 Synergize in the Inhibition of Transforming Growth Factor β Signaling
Datta, P. K., & Moses, H. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3157-3167.2000 · Cited by 175
Geiser, A. G., Burmester, J. K., Webbink, R., Roberts, A. B., & Sporn, M. B. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45921-2 · Cited by 173
Involvement of Myc Activity in a G1/S-Promoting Mechanism Parallel to the pRb/E2F Pathway
Santoni-Rugiu, E., Falck, J., Mailand, N., Bartek, J., & Lukas, J. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3497-3509.2000 · Cited by 172
Song, C.-Z., Tian, X., & Gelehrter, T. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11776 · Cited by 171
Smad2 and Smad4 gene mutations in hepatocellular carcinoma
Yakicier, M. C., Irmak, M. B., Romano, A., Kew, M., & Ozturk, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202866 · Cited by 167
p53-dependent repression of CDK4 translation in TGF-beta-induced G1 cell-cycle arrest.
Ewen, M. E., Oliver, C. J., Sluss, H. K., Miller, S. J., & Peeper, D. S. (1995) · Genes & Development · doi:10.1101/gad.9.2.204 · Cited by 166
Yue, J., & Mulder, K. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000039200 · Cited by 166
Research works printed but not linked: 2
- Caulin, C., Scholl, S.G., Frontelo, P., Gamallo, C. & Quintanilla, M. Chronic exposure of cultured transfected mouse epidermal cells to TGFβ1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype. Cell Growth Diff. 6, 1027–1035 (1995).
- Dickson, R.B. et al. Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17β-estradiol or v-Ha-ras oncogene. Proc. Natl Acad. Sci. USA 84, 837–841 (1987). · DOI · Paper page
Cited by
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Causes and consequences of microRNA dysregulation in cancer
Croce, C. M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2634 · Cited by 2,998
TGF-β-induced epithelial to mesenchymal transition
Xu, J., Lamouille, S., & Derynck, R. (2009) · Cell Research · doi:10.1038/cr.2009.5 · Cited by 2,804
Self-citation
Metadata
- Authors
- Derynck, R., Akhurst, R. J., & Balmain, A.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Derynck, Rik
- Venue
- Nature Genetics
- Published
- 2001-10-01
- Volume
- 29
- Issue
- 2
- Pages
- 117-129
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1565561072
- Cited by
- 2,275
- References
- 319
- Citations by year
- 2026: 21 · 2025: 32 · 2024: 38 · 2023: 59 · 2022: 52 · 2021: 75 · 2020: 71 · 2019: 74 · 2018: 87 · 2017: 87 · 2016: 74 · 2015: 107 · 2014: 120 · 2013: 89 · 2012: 115
- FWCI
- 7.27
- Type
- journal article
- Language
- en
- Update notices
- erratum (2001-11-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- www.springer.com/tdm (unspecified)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- March of Dimes Foundation
- American Heart Association
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- TGF-beta signaling, tumor suppression, tumor progression, carcinogenesis, tumor microenvironment, autocrine and paracrine signaling, tumor invasion, epithelial cells, hematopoietic cells, tumor suppressor, oncogenes
- MeSH terms
- Animals, Humans, Neoplasms, Signal Transduction, Transforming Growth Factor beta, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.